Report Detail

According to our (Global Info Research) latest study, the global GMP-Grade iPSC Master Cell Bank market size was valued at US$ 293 million in 2025 and is forecast to a readjusted size of US$ 795 million by 2032 with a CAGR of 15.2% during review period.
GMP-grade iPSC master cell banks (MCBs) are clinical-grade induced pluripotent stem cell repositories established under GMP or equivalent quality systems. They are derived from donor-derived somatic cells through ethical sourcing (informed consent and donor screening), followed by reprogramming, clone selection, expansion, cryopreservation, and full release testing. These MCBs serve as stable starting materials for the generation of working cell banks (WCBs), gene-edited iPSC lines, directed differentiation products, and downstream cell therapy manufacturing. Their value lies in compliant donor traceability, non-integrating reprogramming methods, genetic stability, sterility and adventitious agent testing, full batch traceability, regulatory documentation readiness, and long-term cryogenic storage management. The estimated gross margin is approximately 58%.
Demand is primarily driven by allogeneic iPSC-based cell therapies, regenerative medicine products, disease modeling platforms, and drug discovery systems. As clinical programs in immune cells, cardiomyocytes, neurons, retinal cells, and other iPSC-derived lineages advance toward late-stage development, developers increasingly prefer GMP-compliant starting materials from the earliest stages. This reduces the risk of re-establishing cell lines, repeating process development, or facing regulatory setbacks later in the development pipeline.
The supply landscape is evolving from standalone cell banking services toward integrated platforms offering clinical-grade seed clones, master cell banks, working cell banks, gene editing services, and regulatory submission documentation packages. Core competitive factors include donor compliance and traceability, non-integrating reprogramming methods, low-passage expansion strategies, genomic and karyotypic stability, viral and adventitious agent testing, closed-system GMP manufacturing workflows, DMF or IND/CTA-ready documentation packages, and demonstrated comparability between research-grade and GMP-grade cell lines.
Regionally, North America, Europe, and Japan lead in regulatory experience, clinical-grade banking infrastructure, and CDMO capabilities. China and South Korea are rapidly scaling domestic GMP iPSC platforms. Key risks include donor authorization complexity, intellectual property constraints, divergent regulatory interpretations across jurisdictions, long release-testing cycles, and high batch production costs. Key opportunities lie in off-the-shelf HLA-matched cell banks, hypoimmunogenic gene-edited iPSC libraries, automated manufacturing systems, and standardized regulatory documentation ecosystems.
Report Scope
This report is a detailed and comprehensive analysis for global GMP-Grade iPSC Master Cell Bank market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global GMP-Grade iPSC Master Cell Bank market size and forecasts, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global GMP-Grade iPSC Master Cell Bank market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GMP-Grade iPSC Master Cell Bank
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GMP-Grade iPSC Master Cell Bank market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM Cellular Dynamics, REPROCELL, Cellistic, I Peace, LineaBio, Catalent, Applied StemCell, CiRA Foundation, Ubrigene, Minaris Advanced Therapies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
GMP-Grade iPSC Master Cell Bank market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Off-the-Shelf GMP iPSC MCB
Custom GMP iPSC MCB
Customer-Owned Line GMP Banking
Technology-Transfer GMP MCB Manufacturing
Market segment by Starting Cell Source
CD34+ Cord Blood-Derived iPSC MCB
Peripheral Blood-Derived iPSC MCB
Fibroblast-Derived iPSC MCB
T Cell-Derived iPSC MCB
Other Somatic Cell-Derived iPSC MCB
Market segment by Quality Documentation Level
Basic GMP-Released iPSC MCB
Extended Characterized iPSC MCB
Viral Safety-Tested iPSC MCB
Filing-Ready iPSC MCB
DMF-Supported iPSC MCB
Market segment by Engineering Status
Unedited iPSC MCB
Reporter or Selection-Marker Edited iPSC MCB
Disease-Model or Corrected iPSC MCB
Immune-Evasion Edited iPSC MCB
Other Engineered iPSC MCB
Market segment by Application
Immune Cell Therapy Development
Regenerative Cell Therapy Development
Gene-Edited Platform Cell Development
Disease Modeling and Drug Screening
Toxicology and Safety Evaluation
Other Clinical Research
Market segment by players, this report covers
FUJIFILM Cellular Dynamics
REPROCELL
Cellistic
I Peace
LineaBio
Catalent
Applied StemCell
CiRA Foundation
Ubrigene
Minaris Advanced Therapies
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe GMP-Grade iPSC Master Cell Bank product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of GMP-Grade iPSC Master Cell Bank, with revenue, gross margin, and global market share of GMP-Grade iPSC Master Cell Bank from 2021 to 2026.
Chapter 3, the GMP-Grade iPSC Master Cell Bank competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and GMP-Grade iPSC Master Cell Bank market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of GMP-Grade iPSC Master Cell Bank.
Chapter 13, to describe GMP-Grade iPSC Master Cell Bank research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of GMP-Grade iPSC Master Cell Bank by Type
    • 1.3.1 Overview: Global GMP-Grade iPSC Master Cell Bank Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global GMP-Grade iPSC Master Cell Bank Consumption Value Market Share by Type in 2025
    • 1.3.3 Off-the-Shelf GMP iPSC MCB
    • 1.3.4 Custom GMP iPSC MCB
    • 1.3.5 Customer-Owned Line GMP Banking
    • 1.3.6 Technology-Transfer GMP MCB Manufacturing
  • 1.4 Classification of GMP-Grade iPSC Master Cell Bank by Starting Cell Source
    • 1.4.1 Overview: Global GMP-Grade iPSC Master Cell Bank Market Size by Starting Cell Source: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global GMP-Grade iPSC Master Cell Bank Consumption Value Market Share by Starting Cell Source in 2025
    • 1.4.3 CD34+ Cord Blood-Derived iPSC MCB
    • 1.4.4 Peripheral Blood-Derived iPSC MCB
    • 1.4.5 Fibroblast-Derived iPSC MCB
    • 1.4.6 T Cell-Derived iPSC MCB
    • 1.4.7 Other Somatic Cell-Derived iPSC MCB
  • 1.5 Classification of GMP-Grade iPSC Master Cell Bank by Quality Documentation Level
    • 1.5.1 Overview: Global GMP-Grade iPSC Master Cell Bank Market Size by Quality Documentation Level: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global GMP-Grade iPSC Master Cell Bank Consumption Value Market Share by Quality Documentation Level in 2025
    • 1.5.3 Basic GMP-Released iPSC MCB
    • 1.5.4 Extended Characterized iPSC MCB
    • 1.5.5 Viral Safety-Tested iPSC MCB
    • 1.5.6 Filing-Ready iPSC MCB
    • 1.5.7 DMF-Supported iPSC MCB
  • 1.6 Classification of GMP-Grade iPSC Master Cell Bank by Engineering Status
    • 1.6.1 Overview: Global GMP-Grade iPSC Master Cell Bank Market Size by Engineering Status: 2021 Versus 2025 Versus 2032
    • 1.6.2 Global GMP-Grade iPSC Master Cell Bank Consumption Value Market Share by Engineering Status in 2025
    • 1.6.3 Unedited iPSC MCB
    • 1.6.4 Reporter or Selection-Marker Edited iPSC MCB
    • 1.6.5 Disease-Model or Corrected iPSC MCB
    • 1.6.6 Immune-Evasion Edited iPSC MCB
    • 1.6.7 Other Engineered iPSC MCB
  • 1.7 Global GMP-Grade iPSC Master Cell Bank Market by Application
    • 1.7.1 Overview: Global GMP-Grade iPSC Master Cell Bank Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.7.2 Immune Cell Therapy Development
    • 1.7.3 Regenerative Cell Therapy Development
    • 1.7.4 Gene-Edited Platform Cell Development
    • 1.7.5 Disease Modeling and Drug Screening
    • 1.7.6 Toxicology and Safety Evaluation
    • 1.7.7 Other Clinical Research
  • 1.8 Global GMP-Grade iPSC Master Cell Bank Market Size & Forecast
  • 1.9 Global GMP-Grade iPSC Master Cell Bank Market Size and Forecast by Region
    • 1.9.1 Global GMP-Grade iPSC Master Cell Bank Market Size by Region: 2021 VS 2025 VS 2032
    • 1.9.2 Global GMP-Grade iPSC Master Cell Bank Market Size by Region, (2021-2032)
    • 1.9.3 North America GMP-Grade iPSC Master Cell Bank Market Size and Prospect (2021-2032)
    • 1.9.4 Europe GMP-Grade iPSC Master Cell Bank Market Size and Prospect (2021-2032)
    • 1.9.5 Asia-Pacific GMP-Grade iPSC Master Cell Bank Market Size and Prospect (2021-2032)
    • 1.9.6 South America GMP-Grade iPSC Master Cell Bank Market Size and Prospect (2021-2032)
    • 1.9.7 Middle East & Africa GMP-Grade iPSC Master Cell Bank Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 FUJIFILM Cellular Dynamics
    • 2.1.1 FUJIFILM Cellular Dynamics Details
    • 2.1.2 FUJIFILM Cellular Dynamics Major Business
    • 2.1.3 FUJIFILM Cellular Dynamics GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.1.4 FUJIFILM Cellular Dynamics GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 FUJIFILM Cellular Dynamics Recent Developments and Future Plans
  • 2.2 REPROCELL
    • 2.2.1 REPROCELL Details
    • 2.2.2 REPROCELL Major Business
    • 2.2.3 REPROCELL GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.2.4 REPROCELL GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 REPROCELL Recent Developments and Future Plans
  • 2.3 Cellistic
    • 2.3.1 Cellistic Details
    • 2.3.2 Cellistic Major Business
    • 2.3.3 Cellistic GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.3.4 Cellistic GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cellistic Recent Developments and Future Plans
  • 2.4 I Peace
    • 2.4.1 I Peace Details
    • 2.4.2 I Peace Major Business
    • 2.4.3 I Peace GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.4.4 I Peace GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 I Peace Recent Developments and Future Plans
  • 2.5 LineaBio
    • 2.5.1 LineaBio Details
    • 2.5.2 LineaBio Major Business
    • 2.5.3 LineaBio GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.5.4 LineaBio GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 LineaBio Recent Developments and Future Plans
  • 2.6 Catalent
    • 2.6.1 Catalent Details
    • 2.6.2 Catalent Major Business
    • 2.6.3 Catalent GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.6.4 Catalent GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Catalent Recent Developments and Future Plans
  • 2.7 Applied StemCell
    • 2.7.1 Applied StemCell Details
    • 2.7.2 Applied StemCell Major Business
    • 2.7.3 Applied StemCell GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.7.4 Applied StemCell GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Applied StemCell Recent Developments and Future Plans
  • 2.8 CiRA Foundation
    • 2.8.1 CiRA Foundation Details
    • 2.8.2 CiRA Foundation Major Business
    • 2.8.3 CiRA Foundation GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.8.4 CiRA Foundation GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 CiRA Foundation Recent Developments and Future Plans
  • 2.9 Ubrigene
    • 2.9.1 Ubrigene Details
    • 2.9.2 Ubrigene Major Business
    • 2.9.3 Ubrigene GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.9.4 Ubrigene GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Ubrigene Recent Developments and Future Plans
  • 2.10 Minaris Advanced Therapies
    • 2.10.1 Minaris Advanced Therapies Details
    • 2.10.2 Minaris Advanced Therapies Major Business
    • 2.10.3 Minaris Advanced Therapies GMP-Grade iPSC Master Cell Bank Product and Solutions
    • 2.10.4 Minaris Advanced Therapies GMP-Grade iPSC Master Cell Bank Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Minaris Advanced Therapies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global GMP-Grade iPSC Master Cell Bank Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of GMP-Grade iPSC Master Cell Bank by Company Revenue
    • 3.2.2 Top 3 GMP-Grade iPSC Master Cell Bank Players Market Share in 2025
    • 3.2.3 Top 6 GMP-Grade iPSC Master Cell Bank Players Market Share in 2025
  • 3.3 GMP-Grade iPSC Master Cell Bank Market: Overall Company Footprint Analysis
    • 3.3.1 GMP-Grade iPSC Master Cell Bank Market: Region Footprint
    • 3.3.2 GMP-Grade iPSC Master Cell Bank Market: Company Product Type Footprint
    • 3.3.3 GMP-Grade iPSC Master Cell Bank Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global GMP-Grade iPSC Master Cell Bank Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global GMP-Grade iPSC Master Cell Bank Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global GMP-Grade iPSC Master Cell Bank Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global GMP-Grade iPSC Master Cell Bank Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America GMP-Grade iPSC Master Cell Bank Consumption Value by Type (2021-2032)
  • 6.2 North America GMP-Grade iPSC Master Cell Bank Market Size by Application (2021-2032)
  • 6.3 North America GMP-Grade iPSC Master Cell Bank Market Size by Country
    • 6.3.1 North America GMP-Grade iPSC Master Cell Bank Consumption Value by Country (2021-2032)
    • 6.3.2 United States GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 6.3.3 Canada GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe GMP-Grade iPSC Master Cell Bank Consumption Value by Type (2021-2032)
  • 7.2 Europe GMP-Grade iPSC Master Cell Bank Consumption Value by Application (2021-2032)
  • 7.3 Europe GMP-Grade iPSC Master Cell Bank Market Size by Country
    • 7.3.1 Europe GMP-Grade iPSC Master Cell Bank Consumption Value by Country (2021-2032)
    • 7.3.2 Germany GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 7.3.3 France GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 7.3.5 Russia GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 7.3.6 Italy GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific GMP-Grade iPSC Master Cell Bank Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific GMP-Grade iPSC Master Cell Bank Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific GMP-Grade iPSC Master Cell Bank Market Size by Region
    • 8.3.1 Asia-Pacific GMP-Grade iPSC Master Cell Bank Consumption Value by Region (2021-2032)
    • 8.3.2 China GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 8.3.3 Japan GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 8.3.5 India GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 8.3.7 Australia GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America GMP-Grade iPSC Master Cell Bank Consumption Value by Type (2021-2032)
  • 9.2 South America GMP-Grade iPSC Master Cell Bank Consumption Value by Application (2021-2032)
  • 9.3 South America GMP-Grade iPSC Master Cell Bank Market Size by Country
    • 9.3.1 South America GMP-Grade iPSC Master Cell Bank Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa GMP-Grade iPSC Master Cell Bank Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa GMP-Grade iPSC Master Cell Bank Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa GMP-Grade iPSC Master Cell Bank Market Size by Country
    • 10.3.1 Middle East & Africa GMP-Grade iPSC Master Cell Bank Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)
    • 10.3.4 UAE GMP-Grade iPSC Master Cell Bank Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 GMP-Grade iPSC Master Cell Bank Market Drivers
  • 11.2 GMP-Grade iPSC Master Cell Bank Market Restraints
  • 11.3 GMP-Grade iPSC Master Cell Bank Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 GMP-Grade iPSC Master Cell Bank Industry Chain
  • 12.2 GMP-Grade iPSC Master Cell Bank Upstream Analysis
  • 12.3 GMP-Grade iPSC Master Cell Bank Midstream Analysis
  • 12.4 GMP-Grade iPSC Master Cell Bank Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on GMP-Grade iPSC Master Cell Bank. Industry analysis & Market Report on GMP-Grade iPSC Master Cell Bank is a syndicated market report, published as Global GMP-Grade iPSC Master Cell Bank Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of GMP-Grade iPSC Master Cell Bank market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report